Proceedings: Characteristics of ouabain inhibition in frog skin.
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001693:Biological Transport, Active; D002104:Cadmium / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007328:Insulin / Q000494:pharmacology; D008564:Membrane Potentials; D010042:Ouabain / Q000494:pharmacology*; D012879:Skin Physiological Phenomena; D012964:Sodium / Q000378:metabolism / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D007328:Insulin; D002104:Cadmium; D014667:Vasopressins; D010042:Ouabain; D000584:Amiloride; D012964:Sodium